Shows
Living HopeThe Hidden Link: Diabetes, Hormones & Pancreatic CancerWe continue the conversation on the link between pancreatic cancer and diabetes with Dr. Afreen Shariff, who explains the vital role hormone specialists play in symptom management and care coordination.
Dr Shariff also introduces Citrus Oncology, her virtual platform offering endocrine support nationwide.
Cindy Gavin of Let’s Win Pancreatic Cancer shares tools like their Clinical Trial Finder and Doctor Finder, along with the value of their fully bilingual website.
2025-05-3128 min
Planetary Health First Mars Next, a Michael Mann production154 Citrus Oncology Co-founders, Aabid Shariff & Afreen Shariff, MDCitrus Oncology Co-founders, Aabid Shariff & Afreen Shariff, MDIn this episode of Planetary Health First Mars Next, we feature Aabid Shariff and Dr. Afreen Shariff, the visionary co-founders of Citrus Oncology, a company reimagining cancer care through tech-enabled navigation and patient-centric solutions.We dive into their journey from idea to execution, their mission to support oncology patients with timely, accessible care, and how Citrus is leveraging data, empathy, and innovation to address gaps in the cancer care continuum.Topics include:The origin story of Citrus OncologyEmpowering patients through better access and navigationChallenges in oncology care deliveryBuilding a tech-forward, patient-first startup...2025-05-2730 minLiving HopeMore Than Sugar: The Overlooked Warning Signs of Pancreatic CancerOn this episode of Living Hope, we explore the powerful connection between diabetes and pancreatic cancer with Dr. Afreen Shariff (Citrus Oncology, Duke University)
and Cindy Gavin (Let’s Win Pancreatic Cancer)
Topics include:
🔹 Diabetes as a warning sign
🔹 Overlapping symptoms & delayed diagnosis
🔹 Blood sugar management in cancer care
🔹 Patient advocacy & awareness
🔹 Let’s Win’s NEW trial & doctor finders
This episode is a powerful reminder that awareness, self-advocacy, and early intervention can make a difference. With organizations like Let’s Win and innovations like Citrus Oncology, patients now have more resources and...2025-03-2222 min
AI and HealthcareSteroids and Hormones in Cancer Care with Dr. Afreen ShariffJoin Dr. Sanjay Juneja, known as the OncDoc, as he discusses the complex intersection of endocrinology and oncology with Dr. Afreen Shariff, an expert endo-oncologist from Duke University. This episode explores the often-overlooked endocrine side effects of cancer treatments, such as steroids and immune therapies, and how they impact patient quality of life. Dr. Shariff shares insights on managing hormonal imbalances, the importance of specialized care, and how platforms like Citrus Oncology are democratizing access to expert opinions and care. Discover how patients can better navigate the challenges of cancer treatment and thrive, supported by comprehensive, multi-specialty care. If...2024-11-2158 min
Succeed in Medicine#402: CONTRIBUTOR’S SERIES— Afreen Shariff MD on Cancer Therapy Side Effects and Endocrine Disorders—- 👋 Freed.AI is here to free you from medical documentation. Join the movement to eliminate clinician burnout. Visit Freed.AI and improve your lifestyle. Coupon Code for $50 off your first paid month: PGD —- 👋 Ready to diversify outside the stock market? EquityMultiple brings you streamlined real estate investing. Access vetted, cash-flowing opportunities from anywhere. Start today, with just $5K, at equitymultiple.com —- 👋 Guest host Dr. Amna Shabbir sits down with Dr. Afreen Shariff, a leading endocrinologist in cancer care, to discuss the intersection of oncology and endocrinology. They explore the c...2024-10-1531 min
The Thyroid Stimulating PodcastManaging Thyroid Adverse Events From Checkpoint InhibitorsDrs Kaniksha Desai and Afreen Shariff discuss the thyroid immune-related adverse effects of immune checkpoint inhibitors. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.staging.medscape.com/partners/ata/public/ata2024-05-0725 min
CANCER BUZZe-Consults for Immune-Related Toxicities Improve Patient Access and Reduce CostsBetween 4% to 15% of patients with cancer who are treated with a class of medications called immune checkpoint inhibitors experience immune-related adverse events (irAEs), including hypothyroidism, hyperthyroidism, and insulin-deficient diabetes. Delayed access, diagnosis, and management of irAEs are often causes of preventable hospital admissions in cancer patients. At Duke Cancer Institute, the implementation of electronic-consults for patients experiencing endocrine irAEs improved patient access and reduced healthcare utilization. Time to appointment and hospitalizations were reduced from 61 days to 39 days and from 11% to 2%, respectively. To propel integration and scalability, the next step is to ensure adequate reimbursement from payers for...2023-08-1006 min
Endocrine News PodcastENP58: OncoendocrinologyToday we shine a spotlight on a fascinating area of focus within endocrinology that maybe you haven't heard much about: oncoendocrinology. What is it, and how are health providers working together to care for patients who have endocrine conditions and cancer? Host Aaron Lohr talks with Afreen I. Shariff, MD, an endocrinologist at Duke University School of Medicine with expertise in endocrine disease in cancer patients. Dr. Shariff is the founding director of the Duke Endocrine-Oncology Program and an associate director for the Cancer Treatment Toxicity Program at the Duke Center for Cancer Immunotherapy. She also chairs the oncoendocrinology special...2022-09-2116 min
Checkpoint NOWEpisode 19: ICI use in Special PopulationsJoin our hosts Dr. Afreen Shariff and Dr. Tian Zhang as they talk to expert oncologists Dr. Sharon and Dr. Nagash to learn about Immune Checkpoint Inhibitors in special populations.Dr. Sharon is an accomplished Oncologist at the National Cancer Institute. He co-Directs immunotherapy trials at the Cancer Therapy Evaluation Program (also known as CTEP) and serves as an attending physician in NCI's Developmental Therapeutics Clinic. As part of his work in immunotherapy drug development, he has made a major effort to advance the understanding of immune-related adverse events, including the establishment of the Alliance-NIH irAE Biorepository. Dr. Naqash, is...2022-02-0840 minCheckpoint NOWEpisode 18: Immune mediated neurological toxicities (Part 2)Learn from the experts about the latest in immune mediated neurological toxicities. Join our hosts Dr. Afreen Shariff and Dr. Tian Zhang as they discuss with guest experts- medical Oncologist Dr. Kerry Reynolds, and expert neurologists Drs. Amanda Guidon and Leeann Burton from Massachusetts General Hospital for an informative and high yield discussion.2021-12-1939 min
Checkpoint NOWEpisode 17: Autoimmune Type 1 Diabetes: Challenge for our patients and cliniciansLearn from the experts about the clinical diagnosis and multidisciplinary management of autoimmune Type 1 Diabetes. Join our hosts Dr. Afreen Shariff and Dr. Tian Zhang as they discuss with guest experts and endocrinologists Dr. Ole-Petter Hamnvik and Dr. Le Min from Brigham and Women's Hospital Harvard Medical School and Dana Farber Cancer Institute for an informative and high yield discussion. 2021-11-1733 min
Cancer.Net PodcastUnderstanding Side Effects of Immune Checkpoint Inhibitors, with Tian Zhang, MD, MHS, and Afreen Idris Shariff, MDASCO: You’re listening to a podcast from Cancer.Net. This cancer information website is produced by the American Society of Clinical Oncology, known as ASCO, the world’s leading professional organization for doctors who care for people with cancer. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be c...2021-11-0111 minCheckpoint NOWEpisode 16: Learning about Immune mediated Adverse events from a trainees persepectiveJoin our hosts Dr. Afreen Shariff and Dr. Tian Zhang as they discuss with resident physicians Dr. Harsh Patolia, Dr. Nathan Hirshman and Dr. Michelle Ferriera who share their experience and tips for fellow residents in training on managing immune mediated adverse events.2021-09-2114 minCheckpoint NOWEpisode 15: Neuro-toxicities from Immune checkpoint Blockade: Rare and complex (Part 1)Learn from the experts about immune mediated neurological toxicities. Join our hosts Dr. Afreen Shariff and Dr. Tian Zhang as they discuss with guest expert and Neurologist Dr. Andrew Mammen. Andrew Mammen, M.D., Ph.D., joined NIAMS as Muscle Disease Unit Leader in the Laboratory of Muscle Stem Cells and Gene Regulation in 2014. He obtained his medical degree and Ph.D. in neuroscience at Johns Hopkins in 2000, where he subsequently completed his medicine internship, neurology residency, and neuromuscular fellowship. Prior to his appointment at NIH, he was Associate Professor of Neurology and Medicine at the Johns H...2021-07-1315 minCheckpoint NOWEpisode 14: Immune Mediated Liver InjuryLearn from the experts about the latest in Immune Mediated Liver Toxicities. Join our hosts Dr. Afreen Shariff and Dr. Tian Zhang as they discuss with guest expert and Transplant Hepatologist Dr. Lindsay King.Dr. King is a Hepatologist, Assistant Professor of Medicine at Duke University School of Medicine.2021-06-1727 minCheckpoint NOWEpisode 13: Skin Toxicities from Immune Checkpoint Inhibitors (PART 2): Common and perplexingHosts: Learn from the experts about the latest in Onco- Dermatology and Immune skin Mediated toxicities. Join our hosts Dr. Afreen Shariff and Dr. Tian Zhang as they discuss with guest expert and Dermatologist Dr. Adela Rambi Cordones. Dr. Cordones is a Dermatologist, Associate Professor of Dermatology at Duke University School of Medicine. She leads the Immunodermatology Clinic at Duke and is clinician investigator with an expertise in Autoimmune Skin Disease and Cutaneous Drug reactions. 2021-05-2617 minCheckpoint NOWEpisode 12: Skin Toxicities from Immune Checkpoint Inhibitors (PART 1): Common and perplexingLearn from the experts about the latest in Onco- Dermatology and Immune skin Mediated toxicities. Join our hosts Dr. Afreen Shariff and Dr. Tian Zhang as they discuss with guest expert and Dermatologist Dr. Meenal Kheterpal. Dr. Kheterpal is a Dermatologist, Assistant Professor of Dermatology at Duke University School of Medicine. She also directs clinical research in Melanoma and Non - Melanoma Skin Cancer at Duke Dermatology.2021-05-0317 minCheckpoint NOWEpisode 11: Onco-Nephrology and Immune Mediated NephrotoxicitiesLearn from the experts about the latest in Onco- Nephrology and Immune Mediated toxicities. Join our hosts Dr. Afreen Shariff and Dr. Tian Zhang as they discuss with guest experts and Nephrologists Dr. Matt Sparks and Dr. David Ortiz-Melo. Dr. Matt Sparks is a Nephrologist, Assistant Professor of Medicine and the Associate program Director for the Nephrology fellowship at Duke. He is also a well-known online celebrity nephrologist who is the program director of the nephrology social media collective internship and co-creator of Nephmadness.Dr. David Ortiz-Melo is a Nephrologist and Assistant Professor of Medicine. D...2021-04-1242 minCheckpoint NOWEpisode 10: Immune Mediated Pulmonary ToxicitiesJoin our hosts Dr. Afreen Shariff and Dr. Tian Zhang as they discuss with guest expert and Oncologist, Dr. Jarushka Naidoo about the complex and challenging diagnosis of Immune mediated Pneumonitis. Dr. Jarushka Naidoo is currently a thoracic oncologist at Beaumont Hospital, Royal College of Surgeons of Ireland and she is also the national lead for lung cancer for Cancer Trials Ireland, and serves as an adjunct professor at Johns Hopkins University. She also serves on the NCCN guidelines committee for the management of immune-related toxicity, and runs an institutional multidisciplinary team for immune toxicity management.2021-03-3027 minCheckpoint NOWEpisode 9: Immune Mediated Cardiac Toxicities: Diagnostic challenges, management and novel discoveries.Join our hosts Dr. Afreen Shariff and Dr. Tian Zhang as they discuss with guest expert Dr. Javid Moslehi, MD, Cardiologist, Associate Professor of Medicine and an expert in immune-mediated cardiotoxicities at Vanderbilt University. Dr. Moslehi is also the Director of Cardio-Oncology at Vanderbilt.2021-03-1627 minCheckpoint NOWEpisode 8: Immune Mediated Colitis- Novel discoveries and novel therapiesLearn from the experts about the latest in scientific trials and novel therapies in the pipeline for management of Immune Mediated Colitis. Join our hosts Dr. Afreen Shariff and Dr. Tian Zhang as they discuss with guest experts- Medical Oncologist- Dr. Kerry Reynolds, Gastroenterologist/ Immunologist- Dr. Micheal Dougan from Massachusetts General Hospital and rising star resident- Dr. Nazli Dizman from Yale for an informative and high yield discussion.2021-03-0327 minCheckpoint NOWEpisode 7: Immune Mediated Colitis and lessons learnt from multidisciplinary team based management.Learn from the experts about the clinical diagnosis and multidisciplinary management of Immune Mediated Colitis. Join our hosts Dr. Afreen Shariff and Dr. Tian Zhang as they discuss with guest experts- medical Oncologist Dr. Kerry Reynolds and Gastroenterologist/ Immunologist Dr. Micheal Dougan from Massachusetts General Hospital for an informative and high yield discussion.2021-02-1632 minCheckpoint NOWEpisode 6: Rheumatic adverse events: Discussions on biomarkers, collaborations and more.Join our hosts Dr. Afreen Shariff and Dr. Tian Zhang as they discuss with guest experts and rheumatologists Dr. Leonard Calabrese and Dr. Cassandra Calabrese from Cleveland Clinic and Dr. Alexa Meara from Ohio State University about budding collaborations and scientific discovery in Immune Mediated Rheumatic Adverse Events2021-02-0224 minCheckpoint NOWEpisode 5: Immune mediated Myositis and Myalgia's: Diagnosis & management for the non-RheumatologistHosts: Join our hosts Dr. Afreen Shariff and Dr. Tian Zhang as they discuss with guest expert and Rheumatologist Dr. Sophia Weinmann about the complex and challenging diagnosis of Immune mediated Myositis and Myalgia’s.2021-01-1816 minCheckpoint NOWEpisode 4: Immune mediated Inflammatory Arthritis: Challenges in diagnosis and managementJoin our hosts Dr. Afreen Shariff and Dr. Tian Zhang as they discuss with guest expert and Rheumatologist Dr. Sophia Weinmann about the complex and challenging diagnosis of immune mediated Inflammatory Arthritis.2021-01-0522 minCheckpoint NOWEpisode 3: Breaking down the diagnosis and management of Immune HypophysitisJoin our host Dr. Afreen Shariff and Dr. Tian Zhang as they discuss all things Immune Hypophysitis and what you need to know to get better at managing this complex adverse event.2020-12-0819 minCheckpoint NOWEpisode 2: Immune Related Thyroid ToxicitiesJoin our hosts Dr. Afreen Shariff and Dr. Tian Zhang as they discuss challenges encountered in the diagnosis and management of commonly encountered Immune related thyroid toxicities.2020-12-0107 minCheckpoint NOWImmune Checkpoint Inhibitors have been transformative for cancer care. What have we learnt so far?Hosts- Dr. Afreen Shariff, MD, Endocrinologist, Assistant Professor of Medicine and Dr. Tian Zhang, MD, Genito-Urinary Oncologist, Assistant Professor of Medicine. Duke University Hospital.2020-11-2410 minCheckpoint NOWCheckpoint NOW2020-08-1700 min